Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs To Use IG's ERGO Software

NEW YORK (GenomeWeb News) - New England Biolabs has licensed Integrated Genomics' ERGO software for gene annotation, metabolic reconstruction, enzyme data mining and comparative genomics research, IG said yesterday.
IG said the ERGO platform integrates data from various types of studies, including genomics, biochemistry, gene expression studies, genetics and literature.
The company said ERGO contains more than 1,180 genomes at “various stages of completion," as well as a network of cellular pathways.
New England Biolabs is a private company that offers recombinant and native enzymes for DNA analysis, genomics, and proteomics.
Financial terms of the agreement were not released.

Filed under

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.